| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.079 | 0.1 |